Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q1 FY27 results · Apr–Jun 2026
Metropolis Healthcare reported revenue from operations of ₹450.21 crore (up 16.6% from Q1 FY26) and net profit of ₹56.88 crore (up 25.7% from Q1 FY26) for Q1 FY27 (Apr–Jun 2026), on a consolidated basis.
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 450.21 | 386.06 | +16.6% | 424.68 | +6.0% |
| Other income | 5.10 | 7.52 | −32.1% | 8.16 | −37.5% |
| Total income | 455.32 | 393.58 | +15.7% | 432.84 | +5.2% |
| Profit before tax | 77.71 | 61.23 | +26.9% | 69.76 | +11.4% |
| Net profit for the period | 56.88 | 45.25 | +25.7% | 50.96 | +11.6% |
| Attributable to shareholders of the company | 56.67 | 45.06 | +25.8% | 50.90 | +11.3% |
| EPS, basic (₹) | 2.73 | 8.70 | not comparable | 2.46 | +11.0% |
| Net margin (%) | 12.6 | 11.7 | 12.0 |
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 372.28 | 323.63 | +15.0% | 352.03 | +5.8% |
| Other income | 5.19 | 2.78 | +86.6% | 8.82 | −41.2% |
| Total income | 377.47 | 326.41 | +15.6% | 360.85 | +4.6% |
| Profit before tax | 66.38 | 47.68 | +39.2% | 59.61 | +11.3% |
| Net profit for the period | 50.58 | 35.58 | +42.2% | 43.24 | +17.0% |
| EPS, basic (₹) | 2.44 | 6.87 | not comparable | 2.09 | +16.7% |
| Net margin (%) | 13.6 | 11.0 | 12.3 |
Consolidated
- Filed with BSE
- 04 Aug 2026, 19:14 IST
- Board meeting
- 04 Aug 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 04 Aug 2026, 19:14 IST
- Board meeting
- 04 Aug 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE